Heron Therapeutics Inc (HRTX)

09:01 AM

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to “Hold” - Defense World

09:01 AM

03:39 AM

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to "Hold" - MarketBeat

03:39 AM

Nov 20, 2024

Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 20, 2024

Nov 20, 2024

Heron Therapeutics Q3 2024 Earnings Preview - MSN

Nov 20, 2024

Nov 19, 2024

Heron Therapeutics Inc (NASDAQ: HRTX) Declines -1.68%: This $177.95 million Stock Could Go Down -669.23% - Stocks Register

Nov 19, 2024

Nov 18, 2024

Short Interest in Heron Therapeutics, Inc. (NASDAQ:HRTX) Declines By 6.0% - MarketBeat

Nov 18, 2024

Nov 17, 2024

Northland Capmk Has Pessimistic View of HRTX Q4 Earnings - Defense World

Nov 17, 2024

Nov 15, 2024

Equities Analysts Set Expectations for HRTX Q4 Earnings - MarketBeat

Nov 15, 2024

Nov 15, 2024

Heron Therapeutics (NASDAQ:HRTX) Raised to Buy at StockNews.com - Defense World

Nov 15, 2024

Nov 14, 2024

Heron Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St

Nov 14, 2024

Nov 13, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Needham & Company LLC Has Lowered Expectations for Heron Therapeutics (NASDAQ:HRTX) Stock Price - MarketBeat

Nov 13, 2024

Nov 13, 2024

Why Investors Shouldn't Be Surprised By Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 30% Share Price Plunge - Simply Wall St

Nov 13, 2024

Nov 13, 2024

Heron Therapeutics Inc (HRTX) Quarterly 10-Q Report - Quartzy

Nov 13, 2024

Nov 13, 2024

Investors Don't See Light At End Of Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Tunnel And Push Stock Down 30% - Simply Wall St

Nov 13, 2024

Nov 13, 2024

Earnings call: Heron Therapeutics projects higher Q4 revenue By Investing.com - Investing.com UK

Nov 13, 2024

Nov 12, 2024

Heron Therapeutics Reports Q3 2024 Results and Narrows Guidance - TipRanks

Nov 12, 2024

Nov 12, 2024

Heron Therapeutics: Q3 Earnings Snapshot - CT Insider

Nov 12, 2024

Nov 12, 2024

Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn

Nov 12, 2024

Nov 12, 2024

Heron Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Heron Therapeutics reports Q3 EPS (3c), consensus (3c) - TipRanks

Nov 12, 2024

Nov 12, 2024

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - PR Newswire

Nov 12, 2024

Nov 10, 2024

Heron Therapeutics (HRTX) Set to Announce Earnings on Tuesday - Defense World

Nov 10, 2024

Nov 07, 2024

Unveiling Heron Therapeutics (HRTX) Q3 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance

Nov 07, 2024

Nov 05, 2024

Heron Therapeutics (HRTX) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024

Nov 05, 2024

Positive Signs As Multiple Insiders Buy Heron Therapeutics Stock - Yahoo Finance UK

Nov 05, 2024

Nov 04, 2024

Heron Therapeutics Strengthens Leadership with New Board Appointment - TipRanks

Nov 04, 2024

Nov 04, 2024

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - StockTitan

Nov 04, 2024

Oct 31, 2024

Bunion Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Heron Therapeutics, Lotus Clinical Research, Cali Pharma, Grünenthal GmbH, Pacira Pharma, Inc, Mallinckrodt - The Globe and Mail

Oct 31, 2024

Oct 29, 2024

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 - Longview News-Journal

Oct 29, 2024

Oct 26, 2024

SG Americas Securities LLC Cuts Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Oct 26, 2024

Oct 21, 2024

Antinauseants Market Insights, Forecast to 2031Heron - openPR

Oct 21, 2024

Oct 20, 2024

The Manufacturers Life Insurance Company Acquires 6,328 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Oct 20, 2024

Oct 16, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Short Interest Update - MarketBeat

Oct 16, 2024

Oct 15, 2024

Heron Therapeutics Inc (HRTX) deserves deeper analysis - US Post News

Oct 15, 2024

Oct 14, 2024

Investor’s Toolkit: Key Ratios for Assessing Heron Therapeutics Inc (HRTX)’s Performance - The Dwinnex

Oct 14, 2024

Oct 12, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLC - Defense World

Oct 12, 2024

Oct 11, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Congress Park Capital LLC - MarketBeat

Oct 11, 2024

Oct 10, 2024

Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI®, SUSTOL®, and APONVIE® as Alternatives During the Potential Shortage of Intravenous Fluids - The Malaysian Reserve

Oct 10, 2024

Oct 09, 2024

Its Stock Has Paid Off Big Time For Heron Therapeutics Inc - SETE News

Oct 09, 2024

Oct 09, 2024

AQR Capital Management LLC Raises Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Oct 09, 2024

Oct 08, 2024

Heron Therapeutics Inc Inc. (HRTX) Price Performance: The Role of Supply and Demand - The InvestChronicle

Oct 08, 2024

Oct 08, 2024

Can you now get a good deal on Heron Therapeutics Inc’s shares? - US Post News

Oct 08, 2024

Oct 06, 2024

Squarepoint Ops LLC Purchases 286,160 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Oct 06, 2024

Oct 03, 2024

Buying Buzz: Heron Therapeutics Inc [HRTX] EVP, Chief Development Officer Forbes William P purchases 25,000 shares of the company – Knox Daily - Knox Daily

Oct 03, 2024

Oct 03, 2024

HRTX’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Oct 03, 2024

Oct 03, 2024

When Can We Expect A Profit From Heron Therapeutics, Inc. (NASDAQ:HRTX)? - Simply Wall St

Oct 03, 2024

Oct 02, 2024

Get in on Heron Therapeutics Inc’s (HRTX) buy-in window today! - SETE News

Oct 02, 2024

Oct 02, 2024

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability - Yahoo Finance

Oct 02, 2024